Carregant...
Allo‐reactive T cells for the treatment of hematological malignancies
Several mechanisms can be responsible for control of hematological tumors by allo‐reactive T cells. Following allogeneic stem cell transplantation (alloSCT) donor T cells recognizing genetic disparities presented on recipient cells and not on donor cells are main effectors of tumor control, but also...
Guardat en:
| Publicat a: | Mol Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528734/ https://ncbi.nlm.nih.gov/pubmed/26578450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.10.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|